| Disease Specific Interactions between Host Protein and DME (HOSPPI) |
| ICD Disease Classification Healthy |
| ICD-11: Healthy |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
| Histone modification |
| Histone deacetylases (HDACs) |
Health |
Repression |
| Uniprot ID |
|
| Interaction Name |
HDACs-TPH1 interaction |
[1] |
| Studied Cell Lines |
Rat islets cell |
| Description |
Histone deacetylases (HDACs) are reported to deacetylate the TPH1 gene and thereby repress the transcriptional activity of the drug-metabolizing enzyme Tryptophan 5-hydroxylase 1. As a result, the interaction between HDACs and TPH1 can inhibit the drug-metabolizing process of Tryptophan 5-hydroxylase 1. |
| ICD Disease Classification 02 Neoplasms |
| ICD-11: 2C10 Pancreatic cancer |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
| Transcription-factor regulation |
| Achaete-scute homolog 1 (ASCL1) |
Pancreatic endocrine tumour |
Repression |
| Uniprot ID |
|
| Interaction Name |
ASCL1-TPH1 interaction |
[2] |
| Studied Cell Lines |
BON1 cell line |
| Ensembl ID |
|
| Description |
Achaete-scute homolog 1 (ASCL1) is reported to repress the transcription of TPH1 gene, which leads to a decreased expression of the drug-metabolizing enzyme Tryptophan 5-hydroxylase 1. As a result, the interaction between ASCL1 and TPH1 can repress the drug-metabolizing process of Tryptophan 5-hydroxylase 1. |
| ICD-11: 2C77 Cervical cancer |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
| Transcription-factor regulation |
| Nuclear TF factor Y beta (NFYB) |
Cervical cancer |
Activation |
| Uniprot ID |
|
| Interaction Name |
NFYB-TPH1 interaction |
[3] |
| Studied Cell Lines |
HeLa cell line |
| Ensembl ID |
|
| Description |
Nuclear TF factor Y beta (NFYB) is reported to activate the transcription of TPH1 gene, which leads to an increased expression of the drug-metabolizing enzyme Tryptophan 5-hydroxylase 1. As a result, the interaction between NFYB and TPH1 can activate the drug-metabolizing process of Tryptophan 5-hydroxylase 1. |
|
|
|
|
|
|